Australia's largest stock trading and investment forum Australia's #1 stock forum

IHL

0.00%

4.1¢ incannex healthcare limited

That is merely the market correction after FOMOing into...

First 79 Last

Share
Profile

Follow
Exalted

1,869 Posts.

1472

03/11/19

14:14

Post #: 41223546
Share

Originally posted by WayneEnterprises: ↑

I’m also thinking we should be at the average of the 3 month period (31 Oct - 1 Aug) being 8.2-8c.

Take a 15% discount rate and we get to 6.8c which if it reaches that level it’s heavily oversold and borderline dangerous where you watch for any breaches below that point.

The price needs to range trade at low to mid 7s for a month to move any seller along.

My 1 year target was at 11c with the capability over a 6-8month time period to reach 20c.

My new short to mid term target has slightly been downgraded. At the moment, the market somewhat likes health stocks which is why it is so important we receive some kind of test result orientated news flow between now and Feb 2020.

Whether it is ironic or sheer coincidence, having a look at BOTs charts and it’s noticeable that every 6months there is a sizeable spike followed by a sizeable sell off which is dating back to 2017.

IHL is slightly similar pattern starting from June 2017.

The monthly chart MACD perspective doesn’t look healthy, however the 5day perspective it looks relatively ok. Which is why I believe it will now range trade until any results from the trials are received from ANZCTR.

Expand

That is merely the market correction after FOMOing into successful trial results. Happens all the time.

For us, anywhere until that first trial rez in forecasted Jan 2020 anything is a steal.

IHL Price at posting: 7.1¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BUX

Buxton projects new graphite province discovery at WA Narryer play

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

There are more pages in this discussion • 612 more messages in this thread...

First 79 Last

Add IHL (ASX) to my watchlist

That is merely the market correction after FOMOing into...

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Buxton projects new graphite province discovery at WA Narryer play

BCI reaches close of funding facility for salt-first part of Mardie project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Featured News